News Minimalist logo

News Minimalist

All news ranked by significance

UNAIDS urges global access to new HIV drug Lenacapavir

Marketscreener.com — July 11, 2024, 09:00 AM UTC

Summary: UNAIDS welcomes Gilead Sciences' successful trial results for Lenacapavir, a long-acting HIV medicine for Pre-Exposure Prevention. The trial showed high efficacy in preventing HIV infections, prompting UNAIDS to urge equitable global access. Concerns arise over Gilead's access strategy for low and middle-income countries, lacking mention of upper-middle-income countries and the Medicines Patent Pool. UNAIDS emphasizes the importance of ensuring access to all who need it to end AIDS by 2030.

Full article

Article metrics
Significance5.1
Scale & Impact0.0
Positivity8.0
Credibility6.5
What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

  1. [4.4]
    Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
    99d 18h
    Source
  2. [6.3]
    New HIV prevention drug lenacapavir shows 100% efficacy (ScienceAlert)
    103d 21h

    ScoresSource
  3. [4.6]
    Biannual Lenacapavir injection 100% effective against HIV (WION)
    105d 20h
    Source
  4. [5.8]
    Lenacapavir injection offers 100% HIV protection to young women (Hindustan Times)
    106d 14h

    ScoresSource
  5. [5.2]
    HIV prevention drug lenacapavir safe and effective in trial (The East African)
    107d 15h

    ScoresSource
  6. [6.1]
    HIV prevention injection successful in South Africa trial (AllAfrica - Top Africa News)
    112d 18h

    ScoresSource